Houdini Bio

Pre-Seed
houdinibio.com AI & Machine Learning London, United Kingdom
Total Funding $2.0M
Latest Round $2.0M Pre-Seed
Last Announced Jun 19, 2026
Investors Undisclosed
Decision Makers Profile Active

About Houdini Bio

Houdini Bio develops computational synthetic biology tools to redesign DNA constructs for improved genetic medicines.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Pre-Seed
Global Headquarters London, United Kingdom
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website houdinibio.com
Domain Registered Date Feb 25, 2025

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $1,987,350 · Pre-Seed

    Pulse 2.0

  2. Milestone

    Website domain registered

    houdinibio.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Houdini Bio.

Funding History

1 Round
Pre-Seed · Jun 19, 2026
$1,987,350 Pulse 2.0

Founders & Leadership

3

Jonathan Cohen-Gold

CEO Co-Founder

Work email & phone locked Unlock →

Lee Dunham

CBO Co-Founder

Work email & phone locked Unlock →

Paul Lehner

Academic Co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts